|
NFKBIA expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.72119996033615E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.37099997810486E-09 |
| Normal-vs-Stage2 |
2.18089990511317E-10 |
| Normal-vs-Stage3 |
1.37699995850227E-09 |
| Normal-vs-Stage4 |
2.26779994783044E-09 |
| Stage1-vs-Stage2 |
4.363700E-02 |
| Stage1-vs-Stage3 |
3.153200E-01 |
| Stage1-vs-Stage4 |
3.028000E-01 |
| Stage2-vs-Stage3 |
3.157800E-01 |
| Stage2-vs-Stage4 |
5.962000E-01 |
| Stage3-vs-Stage4 |
7.288200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.17530004909383E-09 |
| Normal-vs-AfricanAmerican |
9.16619999902224E-08 |
| Normal-vs-Asian |
1.12459996870484E-09 |
| Caucasian-vs-AfricanAmerican |
8.399600E-01 |
| Caucasian-vs-Asian |
1.590040E-01 |
| AfricanAmerican-vs-Asian |
4.331000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.3641003578141E-10 |
| Normal-vs-Female |
3.15049997201555E-09 |
| Male-vs-Female |
1.806240E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.31529999616953E-08 |
| Normal-vs-Age(41-60Yrs) |
1.12959996911854E-09 |
| Normal-vs-Age(61-80Yrs) |
2.95759972068765E-10 |
| Normal-vs-Age(81-100Yrs) |
8.999400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.035010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.163700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.523600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.508200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.260000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.321200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.580100E-02 |
| Classical-VS-Follicular |
1.481790E-01 |
| Classical-VS-Other |
4.975800E-01 |
| Classical-VS-Normal |
5.53169998696035E-09 |
| Tall-VS-Follicular |
2.911200E-01 |
| Tall-VS-Other |
4.428000E-01 |
| Tall-VS-Normal |
1.71689995553947E-10 |
| Follicular-VS-Other |
9.046800E-01 |
| Follicular-VS-Normal |
7.78070052831481E-10 |
| Other-VS-Normal |
4.45760000022943E-08 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.9221999547625E-09 |
| Normal-vs-N1 |
3.62999996728064E-09 |
| N0-vs-N1 |
7.065000E-01 |
|
|
